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Abstract Genetic diseases are recognized to be one of
the major categories of human disease. Traditionally
genetic diseases are subdivided into chromosomal
(numerical or structural aberrations), monogenic or Men-
delian diseases, multifactorial/polygenic complex diseases
and mitochondrial genetic disorders. A large proportion of
these conditions occur sporadically. With the advent of
newer molecular techniques, a number of new disorders
and dysmorphic syndromes are delineated in detail. Some
of these conditions do not conform to the conventional
inheritance patterns and mechanisms are often complex
and unique. Examples include submicroscopic microdele-
tions or microduplications, trinucleotide repeat disorders,
epigenetic disorders due to genomic imprinting, defective
transcription or translation due to abnormal RNA pattern-
ing and pathogenic association with single nucleotide
polymorphisms and copy number variations. Among these
several apparently monogenic disorders result from non-
allelic homologous recombination associated with the
presence of low copy number repeats on either side of the
critical locus or gene cluster. The term ‘disorders of gen-
ome architecture’ is alternatively used to highlight these
disorders, for example Charcot-Marie-Tooth type IA,
Smith-Magenis syndrome, Neurofibromatosis type 1 and
many more with an assigned OMIM number. Many of
these so called genomic disorders occur sporadically
resulting from largely non-recurrent de novo genomic
rearrangements. Locus-specific mutation rates for genomic
rearrangements appear to be two to four times greater than
nucleotide-specific rates for base substitutions. Recent
studies on several disease-associated recombination
hotspots in male-germ cells indicate an excess of genomic
rearrangements resulting in microduplications that are
clinically underdiagnosed compared to microdeletion syn-
dromes. Widespread application of high-resolution genome
analyses may offer to detect more sporadic phenotypes
resulting from genomic rearrangements involving de novo
copy number variation.
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Introduction
Developments in genetics and molecular biology have
provided a vast amount of data and information to support
the view that most human diseases have a significant
genetic component. Characterization of the genetic deter-
minants of disease provides remarkable opportunities for
clinical medicine through an improved understanding of
pathogenesis, diagnosis and therapeutic options. An
understanding of the genetic basis of human disease has
opened the way forward for a new taxonomy of human
disease that will be free from limitations and bias in
developing diagnostic criteria related to events which are
often secondary and peripheral to its cause (Bell 2003). For
instance, genetic information has allowed us to identify
distinct forms of diabetes mellitus, defining an auto-
immune form associated with highly diverse and complex
human leukocyte antigens [HLA] and other factors that
affect both expression and modification of gene products in
mediating the adult form of the disease (Cardon and Bell
2001). Similarly, a number of genetically determined
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molecules and pathways have been characterized that are
crucial in the pathogenesis of bronchial asthma. It is now
widely believed that a clearer understanding of the mech-
anisms and pathways of a disease will assist us in
delineating distinct disease subtypes, and may resolve
many questions relating to variable disease symptoms,
progression and response to therapy. This might help in
revising the current diagnostic criteria. Eventually, genetics
may contribute to a new taxonomy of human disease for
clinical practice.
Although genetics is acknowledged to be an important
aspect in understanding the pathogenesis of disease,
genetic classification of human disease has not yet received
full recognition. There is ample evidence in support of the
argument that genetic factors are probably associated with
all human diseases except probably for trauma. It is argued
that the outcomes to trauma might be influenced by
inherited factors such as genetically determined inflam-
matory markers, host-response to infection and tissue
damage. Various categories of genetic disorders are con-
sidered to be rare with a tendency to be included under the
broad title of organ-system diseases. Often these are listed
as simply etiological factors rather than a distinct disease
category. This concept and approach is now rapidly being
outdated and replaced with new classes of diseases. This
progress is seriously hampered by the lack of formal edu-
cation at all levels and integration of appropriate
technologies into the modern medical diagnostic and
therapeutic infrastructure.
Traditionally, genetic diseases are classified as chro-
mosomal (numerical or structural), Mendelian or single-
gene disorders, multifactorial/polygenic complex diseases
or congenital anomalies and diseases associated with spe-
cific mitochondrial gene mutations. Apart from
chromosomal disorders, essentially all genetic disorders
result from some form of alteration or mutation occurring
in a specific gene (single gene diseases) or involving
multiple loci spread across the human genome (polygenic
disorders). The major impact of chromosomal disorders
occurs before birth and carries a serious health burden
throughout childhood and during the early years of life. On
the other hand single gene diseases can pose a real medical
and health burden from the perinatal period to adult age
with a peak around mid-childhood. In contrast, the poly-
genic/multifactorial diseases tend to present late, except for
developmental anomalies requiring active multi-disciplin-
ary care during early life.
Recent advances in molecular genetics have enabled us
to identify specific groups of disorders that result from
characteristic mechanisms involving specific areas of the
human genome. Often these do not conform to the standard
basic principles of genetics. A broad term ‘genomic dis-
orders’ has been coined to describe these conditions
(Table 1). A number of hereditary disorders present with
complex genetic pathology that do not follow the con-
ventional principles of inheritance. There is now
overwhelming evidence within these disorders that indi-
cates unusual mechanisms suggesting ‘non-traditional
inheritance’. The mechanisms involve certain genomic
regions that directly or indirectly influence regulation and
expression of one or more genes manifesting in complex
phenotypes. Currently some of these disorders are either
listed as chromosomal or single-gene disorders.
Phenotypes of disorders of genome architecture
Recent completion of the human genome project and
sequencing of the total genomes of yeast and other bacte-
rial species have enabled investigators to view genetic
information in the context of the entire genome. As a result
it is now possible to recognize mechanisms of some genetic
diseases at the genomic level. The evolution of the mam-
malian genome has resulted in the duplication of genes,
gene segments and repeat gene clusters (Lupski 1998). This
aspect of genome architecture provides recombination hot
spots between nonsyntenic regions of chromosomes that
are distributed across the whole genome. These genomic
regions become susceptible to further DNA rearrangements
that may be associated with an abnormal phenotype. Such
disorders are collectively grouped under the broad category
of ‘genome architecture disorders’.
The term ‘genome architecture disorder’ refers to a
disease that is caused by an alteration of the genome that
results in complete loss, gain or disruption of the structural
integrity of a dosage sensitive gene(s) (Shaw and Lupski
2004; Lupski and Stankiewicz 2005). Disruption in the
function of dosage sensitive gene may result from number
of mechanisms including gene interruption, gene fusion,
position effect, unmasking of a recessive allele, presence of
a functional polymorphism and gene transvection effect
(Fig. 1). Notable examples include a number of micro-
deletion/duplication syndromes (Table 2). In these condi-
tions, there is a critical rearranged genomic segment
flanked by large (usually[10 kb), highly homologous low
copy repeat [LCR] structures that can act as recombination
substrates. Meiotic recombination between non-allelic
Table 1 Classification of genomic disorders
Disorders of genome architecture (genomic rearrangements)
Disorders of genome architecture (genomic rearrangements)
Tri-nucleotide repeats disorders (genomic instability)
Chromosome breakage disorders (genomic instability)
Non-dysjunction disorders (genomic instability)
Complex genomic diseases (genomic variation-SNPs/CNVs)
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LCR copies, also known as non-allelic homologous
recombination, can result in deletion or duplication of the
intervening segment. The phenotype in some of these
disorders is distinct recognizable with distinguishing clin-
ical and facial dysmorphic features (Fig. 2).
Similarly, other chromosomal rearrangements (Table 3),
including reciprocal, Robertsonian, and jumping translo-
cations, inversions, isochromosomes, and small marker
chromosomes, may also involve susceptibility to rear-
rangement related to genome structure or architecture. In
several cases, LCRs, A–T rich palindromes and pericen-
tromeric repeats are located at such rearrangement
breakpoints. This susceptibility to genomic rearrangements
is not only implicated in disease etiology, but also in pri-
mate genome evolution (Shaw and Lupski 2004).
An increasing number of Mendelian diseases (Table 3)
are recognized to result from recurrent inter and intra
chromosomal rearrangements involving unstable genomic
regions facilitated by low-copy repeats [LCRs]. These
genomic regions are predisposed to non-allelic homologous
recombination [NAHR] between paralogous genomic seg-
ments. LCRs usually span approximately 10–400 kb of
genomic DNA, share 97% or greater sequence identity, and
provide the substrates for NAHR, thus predisposing to
rearrangements. LCRs have been shown to facilitate mei-
otic DNA rearrangements associated with several multiple
malformation syndromes and some disease traits (Table 2).
Seminal examples (Fig. 3) include microdeletion syn-
dromes [Williams-Beuren syndrome (7q11del), DiGoerge
syndrome (22q11del)], autosomal dominant Charcot-
Marie-Tooth disease type 1A [PMP22 gene duplication],
Hereditary Neuropathy of Pressure Palsy [HNPP: PMP22
Fig. 1 Molecular mechanisms for genomic disorders (Lupski and
Stankiewicz 2005)—dashed lines indicate either deleted or duplicated
region; the rearranged genomic interval is shown in brackets; gene is
depicted by filled horizontal rectangle; regulatory gene is shown as
horizontal hach-marked rectangle; asterisks denote point mutations
Table 2 Selected disorders of genome architecture
Disorder Inheritance Locus Gene Rearrangement Repeat size (kb) Reference
Type Size (kb)
Williams-Beuren syndrome AD 7q11.23 ELN del/inv 1600 [320 } Somerville et al. (2005)
Dup7(q11.23) syndrome ? 7q11.23 ? dup }
Prader-Willi syndrome AD 5q11.2q13 ? del 3500 [500 }
Angelman syndrome AD 15q11.2q13 UBE3A del 3500 [500 } Long et al. (1998)
Dup(15)(q11.2q13) AD? 15q11.2q13 ? dup 3500 [500 }
Triplication 15q11.2q13 AD? 15q11.2q13 ? trip [500 }
Smith-Magenis syndrome AD? 17p11.2 RA13 del 4000 *250 } Potocki et al. (2000)
Potocki-Luspki syndrome AD 17p11.2 ? dup }
CMT1A AD 17p11.2 PMP22 dup 4000 *250 } Chance et al. (1994)
HNPP AD 17p11.2 PMP22 del }
Neurofibromatosis type 1 AD 17q NF1 del De Luca et al. (2007)
DiGoerge/VCFS AD 22q11.2 TBX1 del 3000 *400 } Edelman et al. (1999)
Dup 22(q11.2q11.2) syndrome ?AD 22q11.2 ? dup }
Sotos syndrome AD NSD1 del Rauch and Do¨rr (2007)
Male infertility YL Yq11.2 DBY del 800 *10 } Blanco et al. (2000)
AZFa-HERV microdeletion USP9Y del
AZFc microdeletion YL Yq11.2 RBMY DAZ? del 3500 *220 } Boch and Jobling (2003)
del, deletion; dup, duplication; inv, inversion
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gene deletion] mapped to 17p11.2 and Smith-Magenis, a
contiguous gene syndrome [CGS] with del (17)
(p11.2p11.2). Dominantly inherited male infertility related
to AZF gene deletion follows a similar mechanism. In
addition this LCR-based complex genome architecture
appears to play a major role in the primate karyotype
evolution, pathogenesis of complex traits and human car-
cinogenesis (Frank et al. 2007).
Fig. 2 Selected disorders of the genome architecture-Williams-
Beuren syndrome (1); Beckwith-Wiedemann syndrome (2); Prader-
Willi syndrome (3); Angelman syndrome (4); Smith-Magenis
syndrome (5); CMTIA (6); Sotos syndrome (7);Neurofibromatosis-1
(8); 22q deletion syndrome (9,10)
Table 3 Genomic diseases resulting from recurrent genomic rearrangements
Rearrangement Type Recombination substrates
Repeat size Identity (%) Orientation Type
Inv dup(15)(q11q13) Inverted dup [500 C




inv/dup/del *400 95–97 I Olfactory receptor gene cluster
dup(15)(q24q26) dup *13–60 ?
del, deletion; dup, duplication; inv, inversion; D, direct; C, complex; I, inverted




from Nature Genetics, Turner
et al. 2008)
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Most commonly NAHR occurs between highly similar
duplicated sequences. NAHR between duplicated sequen-
ces in direct orientation results in deletion or duplication
ofintervening sequences. In contrast, inversions result from
NAHR between sequences aligned in inverted orientation
(Turner et al. 2008). The predominant pathogenic mecha-
nism for the genomic disorders associated with deletions
and duplications is altered copy number of dosage sensitive
genes (Lupski and Stankiewicz 2005). In addition, NAHR
is probably the most prevalent mechanisms contributing to
non-pathogenic genomic variation (Redon et al. 2006). The
breakpoints of genomic rearrangements caused by NAHR
have been shown to cluster in defined hot spots within
duplicated sequences, in a manner similar to allelic
recombination hot spots (Turner et al. 2008). NAHR can
occur in a number of ways. A simple model suggests three
mechanisms—between paralogs on the same chromatid
(intrachromatid), between sister chromatids (interchroma-
tid), and between homologous chromosomes
(interchromosomal). Deletion or duplication products
result from the latter two mechanisms (Fig. 3). According
to this model of NAHR, the relative rate of deletion and
duplication depends on frequency of intrachromatid NAHR
during meiosis. It is estimated that the rate of duplication
never exceeds that of deletion (Turner et al. 2008).
A notable example includes genetically heterogeneous
Charcot-Marie-Tooth disease [CMTD]. The disorder is
also known as hereditary motor and sensory neuropathy
[HMSN] by virtue of being a peripheral neuropathy due to
either involvement of the axonal or myelinated segments of
the peripheral nerve. Genetically autosomal dominant,
autosomal recessive and X-linked dominant types are rec-
ognized. The disorder is not uncommon affecting
approximately 1 in 2,500 of the adult population. This
could be an underestimate since medically the condition is
benign often not requiring any medical and/or surgical
intervention. However, some affected individuals experi-
ence increasingly progressive neuro-muscular weakness of
distal muscles of lower legs, feet, distal forearms, and
hands with onset in early teens and causing severe loco-
motor restrictions.
An affected person usually presents late with relative
hypertrophy of the upper calf muscles described as
‘inverted Champagne bottle’ associated with pes cavus due
to wasting of the small muscles of the feet. Similarly,
wasting of the small muscles of hand leads to ‘claw-hands’.
Neurophysiological studies remain an essential method of
differentiating the two major types of CMTD. A reduced
motor nerve conduction velocity of less than 35 m/sec
helps in differentiating type 1 CMTD from type 2 CMTD,
in which the motor nerve conduction velocity is usually
normal but the sensory nerve conduction is often slow.
Whilst this distinction is undoubtedly helpful in the clinical
management, application for genetic counseling is limited
because both types are genetically heterogeneous. For
instance, molecular characterization and gene mapping
have confirmed the existence of at least four types of type 1
CMTD, autosomal dominant types 1a, 1b, and 1c and the
X-linked type [XCMT]. Similarly there are distinct genetic
types within the type 2 CMTD group.
Approximately two-thirds of cases of CMT1 have a
detectable 1.5 Mb duplication within a proximal chromo-
somal segment of the short arm of chromosome 17 (17p12)
(Lupski et al. 1991). This duplicated chromosomal segment
contains a gene for peripheral myelin protein called PMP22.
This duplication results in disruption of the gene leading to
abnormal myelination of the peripheral nerves, an essential
molecular pathological step resulting in the CMT1 pheno-
type designated as CMT1A. The CMT1A duplication was
visualized by multiple molecular methods (Patel and Lupski
1994), including fluorescence in situ hydridisation [FISH],
pulsed-field gel eletrophoresis [PFGE], and dosage differ-
ences of heterozygous alleles by restriction-fragment-length
polymorphisms [RFLPs] (Fig. 4). This finding led to further
molecular studies on the origin of the 1.5 Mb duplicated
17p12 segment (Lupski 2003).
Studies by several investigators have revealed a signif-
icant variation in the size of marker alleles flanking the
duplicated 17p12 region. It soon became apparent that a
500 kb allele co-segregated with 17p duplication in all
affected individuals. This suggested a stable mutation and
followed a precise recombination mechanism. However, in
de novo duplication, the presence of repeated flanking
marker alleles indicated the mechanism of unequal-cross-
ing over leading to duplication. Indeed, this was confirmed
when a highly homologous [20 kb size repeat sequence
was confirmed flanking the 17p duplication. It was appro-
priately termed ‘‘CMT1A-REP.’’ As predicted by the
unequal crossing-over model, CMT1A-REP was found to
be present in three copies on the CMT1A duplication-
bearing chromosome (Pentao et al. 1992). Interestingly, the
presence of only one copy was soon demonstrated in
another peripheral nervous system disorder known as
hereditary neuropathy with liability to pressure [HNPP]
(Chance et al. 1994; Reiter et al. 1996). The affected
individuals with this disorder present with mild to moder-
ate episodic weakness of the lower limbs and occasionally
of upper limbs when subjected to prolonged pressure, such
as sitting and sleeping. The disorder is dominantly inher-
ited in an autosomal dominant manner. This is generally a
clinically mild and benign hereditary neuropathy. The
presence of only one copy results from a reciprocal dele-
tion following unequal crossing-over involving the
CMT1A-REP repeat (Fig. 5).
Similar observations were also made in relation to
Smith-Magenis syndrome (SMS), a contiguous gene
Genomic Med. (2008) 2:69–76 73
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syndrome associated with a microdeletion of 17p11.2
segment (Greenberg et al. 1991). Affected children present
with facial dysmorphic features, severe speech delay and
behavioural problems with signs of self-harm. A specific
junction fragment was detected by PFGE (SMS-REP) that
was involved in recurrent rearrangement resulting in either
SMS or reciprocal 17p11.2 duplication. Pathogenic muta-
tions in RAI1 gene, mapped to the 17p11.2 chromosomal
region, are now shown to be etiologically linked with SMS
(Slager et al. 2003). It is also possible to have both
duplication and deletion at the same time, resulting from
DNA rearrangements on both homologues of chromosome
17. This was demonstrated in a patient with mild delay and
a family history of autosomal dominant carpel-tunnel
syndrome, designated as Potocki–Lupski syndrome (Po-
tocki et al. 1999, 2007). The occurrence of both the
17p11.2 duplication and HNPP deletion in this patient
reflects the relatively high frequency at which these
abnormalities arise and the underlying molecular charac-
teristics of the genome in this region.
It is perfectly reasonable to accept the argument that
similar molecular mechanisms apply in causing several
other apparently Mendelian disorders often occurring
sporadically (Table 4) (Lee et al. 2007). The human gen-
ome has evolved an architecture that may make us as a
species more susceptible to de novo rearrangements caus-
ing genomic disorders (Lupski 2003, 2007). Several
questions remain to be answered. To what extent de novo
mutations result in sporadic traits? What is the difference in
mutations rates for locus-specific point mutation or geno-
mic rearrangement resulting in clinically indistinguishable
phenotype? Is there any difference in male-germ cells
meiotic genomic rearrangements resulting in either mic-
rodeletions or microduplications? Recent studies point to
an excess of genomic rearrangement hot spots in male
germ cells. Deletions are generated at a relatively higher
rate that reciprocal duplications in the male germline
(Turner et al. 2008).
Rapid developments in this direction, for example
commercially available opportunities for individual whole
CMT1A










Fig. 4 The 1.5 Mb duplicated
chromosomal region of 17p12
including the PMP22 gene—
note 500 kb junction fragment
allele flanking the CMT1A gene
detected by PFGE and Southern
analysis. Note additional 17p
segment (red colour) by
metaphase (top two pictures)
and interphase (lower two
pictures) FISH (Reproduced
with permission from Oxford







Fig. 5 The unequal meiotic recombination (crossing-over) resulting
in duplication [CMT1A] and deletion [HNPP]
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human genome sequencing or whole genome scan using a
1,000,000-probe SNP chip might offer to answer some of
these questions. Currently probably the best results are likely
to be achieved through multi-institutional efforts for devel-
oping better arrays for high-resolution genome analyses and
detection of copy-number variation in conjunction with
robust data bases (Lupski 2007), for example ‘Database of
Genomic Variants’ (http://projects.tcag.ca/variation/) and
DECIPHER-database for chromosomal imbalance and
phenotype in humans using Ensembl (www.ensembl.org)
resources (http://www.sanger.ac.uk/PostGenomics/decipher/
). In conclusion, for many apparent sporadic diseases, and
perhaps for multi-factorial and complex traits, one must
consider the possibility of de novo genomic rearrangement as
the potential molecular mechanism (Lupski 2007). Several
research groups are engaged in looking for more genomic
recombination hot spots that could reveal more disorders
informing both clinical genetics and other clinicians (Osborne
2008). There is now ample evidence for the existence of dis-
tinct clinical conditions that result from a number of genomic
mechanisms related to either disruption in the genome archi-
tecture/function or both. Term ‘genomic disorders’ is
probably appropriate to designate these conditions as a new
class of human disease included in the taxonomy for human
disease.
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